An efficacy study of abatacept in patients with steroid-refractory chronic graft versus host disease
Latest Information Update: 20 Jan 2022
At a glance
- Drugs Abatacept (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
Most Recent Events
- 20 Jan 2022 New trial record
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition